46 related articles for article (PubMed ID: 7030715)
1. [Pharmacokinetic studies of 5-nitrox in kidney failure patients].
Mikhaĭlova D; Viktorov I; Dzhoneĭdi M; Mikhaĭlova S; Tsenova Z
Eksp Med Morfol; 1981; 20(3):160-6. PubMed ID: 7030715
[TBL] [Abstract][Full Text] [Related]
2. [COmparative pharmacokinetic studies of 5-nitrox and 5-NOK in volunteers].
Makhaĭlova D; Tsenova Z; Dzhoneĭdi M; Mikhaĭlova S
Eksp Med Morfol; 1981; 20(3):156-60. PubMed ID: 7030714
[TBL] [Abstract][Full Text] [Related]
3. [Pharmacokinetics of dibekacin in patients with chronic renal impairment].
Viotte G; Leroy A; Godin M; Fillastre JP
Nouv Presse Med; 1982 Nov; 11(46):3414-8. PubMed ID: 7155849
[TBL] [Abstract][Full Text] [Related]
4. Nesiritide does not improve renal function in patients with chronic heart failure and worsening serum creatinine.
Wang DJ; Dowling TC; Meadows D; Ayala T; Marshall J; Minshall S; Greenberg N; Thattassery E; Fisher ML; Rao K; Gottlieb SS
Circulation; 2004 Sep; 110(12):1620-5. PubMed ID: 15337695
[TBL] [Abstract][Full Text] [Related]
5. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
6. Differential effect of chronic renal failure on the pharmacokinetics of lidocaine in patients receiving and not receiving hemodialysis.
De Martin S; Orlando R; Bertoli M; Pegoraro P; Palatini P
Clin Pharmacol Ther; 2006 Dec; 80(6):597-606. PubMed ID: 17178261
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of oxazepam following multiple administration in volunteers and patients with chronic renal disease.
Busch U; Molzahn M; Bozler G; Koss FW
Arzneimittelforschung; 1981; 31(9):1507-11. PubMed ID: 7197965
[TBL] [Abstract][Full Text] [Related]
8. High serum enalaprilat in chronic renal failure.
Elung-Jensen T; Heisterberg J; Kamper AL; Sonne J; Strandgaard S; Larsen NE
J Renin Angiotensin Aldosterone Syst; 2001 Dec; 2(4):240-5. PubMed ID: 11881130
[TBL] [Abstract][Full Text] [Related]
9. Hereditary nephropathy associated with hyperuricemia and gout.
Puig JG; Miranda ME; Mateos FA; Picazo ML; Jiménez ML; Calvin TS; Gil AA
Arch Intern Med; 1993 Feb; 153(3):357-65. PubMed ID: 8427538
[TBL] [Abstract][Full Text] [Related]
10. A dramatic reduction of normalized protein catabolic rate occurs late in the course of progressive renal insufficiency.
Chandna SM; Kulinskaya E; Farrington K
Nephrol Dial Transplant; 2005 Oct; 20(10):2130-8. PubMed ID: 15956057
[TBL] [Abstract][Full Text] [Related]
11. [Copper and zinc metabolic derangement in patients with chronic pyelonephritis developing nephrosclerosis and renal insufficiency].
Pavlov SB
Urol Nefrol (Mosk); 1998; (1):7-9. PubMed ID: 9532935
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of PTH/PTHrP receptor in the kidney of patients with renal impairment.
Chen J; Zhang J; Lin S
Chin Med J (Engl); 1998 Jan; 111(1):24-7. PubMed ID: 10322647
[TBL] [Abstract][Full Text] [Related]
13. Oxidative stress in chronic renal failure patients treated by peritoneal dialysis.
Al-Hashimi AF; Mohammed FH; Al-Khazragi AS
Saudi Med J; 2004 Sep; 25(9):1186-92. PubMed ID: 15448763
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of recombinant hirudin in hemodialyzed end-stage renal failure patients.
Vanholder R; Camez A; Veys N; Van Loo A; Dhondt AM; Ringoir S
Thromb Haemost; 1997 Apr; 77(4):650-5. PubMed ID: 9134637
[TBL] [Abstract][Full Text] [Related]
15. Long-term outcome of repeated lead chelation therapy in progressive non-diabetic chronic kidney diseases.
Lin-Tan DT; Lin JL; Yen TH; Chen KH; Huang YL
Nephrol Dial Transplant; 2007 Oct; 22(10):2924-31. PubMed ID: 17556414
[TBL] [Abstract][Full Text] [Related]
16. [Morpho-functional study of the kidney in patients with kidney disease and liver disease with magnetic resonance].
Shariat Razavi I; Stacul F; Cova M; Artero M; Carraro M; Malalan F; Pozzi Mucelli R; Dalla Palma L
Radiol Med; 1998; 95(1-2):72-81. PubMed ID: 9636731
[TBL] [Abstract][Full Text] [Related]
17. Clinical and morphological prognostic factors in membranous nephropathy: significance of focal segmental glomerulosclerosis.
Dumoulin A; Hill GS; Montseny JJ; Meyrier A
Am J Kidney Dis; 2003 Jan; 41(1):38-48. PubMed ID: 12500220
[TBL] [Abstract][Full Text] [Related]
18. Plasma adiponectin concentrations in patients with chronic renal failure: relationship with metabolic risk factors and ischemic heart disease.
Tentolouris N; Doulgerakis D; Moyssakis I; Kyriaki D; Makrilakis K; Kosmadakis G; Stamatiadis D; Katsilambros N; Stathakis C
Horm Metab Res; 2004 Oct; 36(10):721-7. PubMed ID: 15523599
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic aspects of thiamphenicol in subjects with normal renal function and in patients with chronic renal insufficiency, with or without haemodialysis.
Tacquet A; Devulder B; Cuvelier D; Legros J
Postgrad Med J; 1974 Oct; 50 Suppl 5():36-8. PubMed ID: 4470815
[No Abstract] [Full Text] [Related]
20. [Results of application of the preparation Lespenephryl Lyophylise injections in chronic renal failure].
Czekalski S
Pol Tyg Lek; 1969 Feb; 24(7):243-5. PubMed ID: 4892814
[No Abstract] [Full Text] [Related]
[Next] [New Search]
